Ann Lab Med.  2015 Nov;35(6):660-662. 10.3343/alm.2015.35.6.660.

Anti-Rods and Rings Autoantibodies in a Patient With Hepatitis C Virus Infection

• Choi KH
• Lim YA
• Kim TY
• Jearn LH
• Baik SY
• Cho SW
• Jeong E

• KMID: 2363275
• DOI: http://doi.org/10.3343/alm.2015.35.6.660

Abstract

No abstract available.

MeSH Terms

Aged
Antibodies, Antinuclear/analysis/*immunology
Antiviral Agents/therapeutic use
Fluorescent Antibody Technique
Hepatitis C/*diagnosis/drug therapy
Humans
Liver Failure/diagnosis/immunology
Male
Antibodies, Antinuclear
Antiviral Agents

Figure

• 

  Fig. 1 (A) Cytoplasmic rods and rings of HEp-2 cells with FITC-conjugated goat anti-human immunoglobins (Medical & Biological Laboratories Co., Ltd., Nagoya, Japan) in sera from the patient with hepatitis C virus infection (×200). (B) Cytoplasmic pattern (autoantibodies recognizing mitotic spindle apparatus-related antigens) observed with Kallestad HEp-2 cell line substrate (Bio-Rad Laboratories, Hercules, CA, USA) in sera from the patient with hepatitis C virus infection (×200).

Reference

1. Vermeersch P, Bossuyt X. Prevalence and clinical significance of rare antinuclear antibody patterns. Autoimmun Rev. 2013; 12:998–1003. PMID: 23583982.

2. Liberal R, Mieli-Vergani G, Vergani D. Clinical significance of autoantibodies in autoimmune hepatitis. J Autoimmun. 2013; 46:17–24. PMID: 24016388.

3. Carcamo WC, Ceribelli A, Calise SJ, Krueger C, Liu C, Daves M, et al. Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients. J Clin Immunol. 2013; 33:420–426. PMID: 23100146.

4. Covini G, Carcamo WC, Bredi E, von Mühlen CA, Colombo M, Chan EK. Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Antivir Ther. 2012; 17:805–811. PMID: 22293655.

5. Carcamo WC, Satoh M, Kasahara H, Terada N, Hamazaki T, Chan JY, et al. Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells. PLoS One. 2011; 6:e29690. PMID: 22220215.

6. Stinton LM, Myers RP, Coffin CS, Fritzler MJ. Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection. BMC Gastroenterol. 2013; 13:50. PMID: 23506439.

7. Novembrino C, Aghemo A, Ferraris Fusarini C, Maiavacca R, Matinato C, Lunghi G, et al. Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients. J Viral Hepat. 2014; 21:944–949. PMID: 25040504.

8. Keppeke GD, Nunes E, Ferraz ML, Silva EA, Granato C, Chan EK, Andrade LE. Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-α. PLoS One. 2012; 7:e45392. PMID: 23028980.